Johnson & Johnson looking to buy eye disease biotech for up to $3.4bn

rss · ft 2026-11-15T23:54:31Z en
Drugmaker’s potential acquisition of Ollin Biosciences is latest in glut of deals in biotechnology sector

This article is available on the publisher's site.

Read on ft
Highlight